NYSE · THW · USD
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 02:44 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Abrdn World Healthcare Fund’s quoted price sits in the upper half of its reported 52-week range, 11.06% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Abrdn World Healthcare Fund’s forward annual dividend is $1.32 per share, paid monthly. The forward yield is 10.24% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Abrdn World Healthcare Fund’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Under the stewardship of Tekla Capital Management LLC, the Tekla World Healthcare Fund functions as a balanced, closed-end mutual fund. Its investment mandate extends to publicly traded stocks and debt instruments spanning international markets. A primary focus for its equity allocations is businesses within the healthcare industry, while the debt component of its portfolio largely comprises corporate bonds. Established on June 26, 2015, this fund is headquartered in the United States.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 02:48 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$47.63-$0.67 (-1.39%)
T. Rowe Price Institutional Emerging Markets Equity Fund’s quoted price sits in the upper half of its reported 52-week range, 11.91% below the high.
$118.99-$1.59 (-1.32%)
Alger Focus Equity Z’s quoted price sits in the upper half of its reported 52-week range, 8.34% below the high.
$43.56-$0.09 (-0.21%)
Evercore Equity Fund’s quoted price sits in the upper half of its reported 52-week range, 3.39% below the high.
$11.08-$0.02 (-0.18%)
Blackstone Strategic Credit Fund’s quoted price sits in the lower half of its reported 52-week range, 7.74% below the high.
$10.77$0.00 (0.0%)
BlackRock MuniYield Fund, Inc.’s quoted price sits in the upper half of its reported 52-week range, 1.34% below the high.
$17.50$0.00 (0.0%)
T. Rowe Price Target Retirement 2035 Fund’s quoted price sits in the upper half of its reported 52-week range, 1.8% below the high.
$14.02-$0.08 (-0.53%)
Guggenheim Active Allocation Fund’s quoted price sits in the lower half of its reported 52-week range, 14.85% below the high.
$8.10-$0.03 (-0.32%)
PIMCO California Municipal Income Fund’s quoted price sits in the lower half of its reported 52-week range, 11.82% below the high.
